Generation and Characterization of Stable Small Colony Variants of USA300 Staphylococcus aureus in RAW 264.7 Murine Macrophages.
Dalida BivonaCarmelo BonomoLorenzo ColombiniPaolo Giuseppe BonacciGrete Francesca PriviteraGiuseppe CarusoFilippo CaraciFrancesco SantoroNicolò MussoDafne BongiornoFrancesco IannelliStefania StefaniPublished in: Antibiotics (Basel, Switzerland) (2024)
Intracellular survival and immune evasion are typical features of staphylococcal infections. USA300 is a major clone of methicillin-resistant S. aureus (MRSA), a community- and hospital-acquired pathogen capable of disseminating throughout the body and evading the immune system. Carnosine is an endogenous dipeptide characterized by antioxidant and anti-inflammatory properties acting on the peripheral (macrophages) and tissue-resident (microglia) immune system. In this work, RAW 264.7 murine macrophages were infected with the USA300 ATCC BAA-1556 S. aureus strain and treated with 20 mM carnosine and/or 32 mg/L erythromycin. Stable small colony variant (SCV) formation on blood agar medium was obtained after 48 h of combined treatment. Whole genome sequencing of the BAA-1556 strain and its stable derivative SCVs when combining Illumina and nanopore technologies revealed three single nucleotide differences, including a nonsense mutation in the shikimate kinase gene aroK . Gene expression analysis showed a significant up-regulation of the uhpt and sdrE genes in the stable SCVs compared with the wild-type, likely involved in adaptation to the intracellular milieu .
Keyphrases
- staphylococcus aureus
- genome wide identification
- methicillin resistant staphylococcus aureus
- copy number
- anti inflammatory
- genome wide
- wild type
- healthcare
- biofilm formation
- mental health
- oxidative stress
- reactive oxygen species
- emergency department
- dna methylation
- transcription factor
- genome wide analysis
- single cell
- pseudomonas aeruginosa
- protein kinase
- spinal cord
- adverse drug
- replacement therapy
- electronic health record